Novel PET imaging agent targets copper in tumors, detects prostate cancer recurrence early

(Society of Nuclear Medicine and Molecular Imaging) An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a novel nuclear medicine imaging agent targeting copper accumulation in tumors can detect prostate cancer recurrence early in patients with biochemical relapse (rising prostate-specific antigen [PSA] level).